Altaris Partners, LLC 4
Accession 0001209191-20-043394
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 7:14 PM ET
Size
36.6 KB
Accession
0001209191-20-043394
Insider Transaction Report
- Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−18$251→ 329 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−294,591$4,109,544→ 5,465,970 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−851,693$11,881,117→ 23,003,209 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−195,152$2,722,370→ 5,270,818 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−12$167→ 317 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−1,285,669$17,935,083→ 23,854,902 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-20$13.95/sh−4$56→ 76 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2020-07-22$13.95/sh−3$42→ 73 total(indirect: See footnotes)
Footnotes (10)
- [F1]Pursuant to an underwriting agreement, dated July 15, 2020 (the "Underwriting Agreement"), and in connection with the registered public offering of shares of common stock of the Issuer, pursuant to the final prospectus supplement dated July 15, 2020, which sale was completed on July 20, 2020, the underwriters purchased, and each of AHP-TH LLC, AHP-BHC LLC, ACP-TH LLC and ACP-BHC LLC, as selling stockholders (collectively, the "Selling Stockholders"), sold, an aggregate of 1,580,282 shares of common stock of the Issuer.
- [F10]The underwriters' purchase of additional shares of common stock from the Selling Stockholders pursuant to the underwriters' over-allotment option under the Underwriting Agreement closed on July 22, 2020.
- [F2]The securities are held of record by AHP-TH LLC.
- [F3]Altaris Health Partners III, L.P. is the sole owner of each of AHP-TH LLC and AHP-BHC LLC, and may be deemed to beneficially own the shares of common stock of the Issuer owned by each of AHP-TH LLC and AHP-BHC LLC. AHP III GP, L.P. is the general partner of Altaris Health Partners III, L.P., and may be deemed to beneficially own the shares of common stock of the Issuer beneficially owned by Altaris Health Partners III, L.P. Altaris Partners, LLC is the general partner of AHP III GP, L.P., and may be deemed to beneficially own the shares of common stock of the Issuer beneficially owned by AHP III GP, L.P.
- [F4]George Aitken-Davies and Daniel Tully are the Managers of Altaris Partners, LLC. Each of Mr. Aitken-Davies and Mr. Tully is in a position directly and indirectly to determine the investment and voting decisions made by Altaris Partners, LLC and the affiliated entities listed above. Mr. Aitken-Davies and Mr. Tully may each be deemed to have voting and investment power with respect to all shares of common stock of the Issuer held beneficially by Altaris Partners, LLC through the reporting persons described in these footnotes.
- [F5]Each reporting person disclaims beneficial ownership of all shares of common stock of the Issuer except to the extent of his or its pecuniary interest therein.
- [F6]The securities are held of record by AHP-BHC LLC.
- [F7]The securities are held of record by ACP-TH LLC.
- [F8]Altaris Constellation Partners, L.P. is the sole owner of each of ACP-TH LLC and ACP-BHC LLC, and may be deemed to beneficially own the shares of common stock of the Issuer owned by each of ACP-TH LLC and ACP-BHC LLC. AHP Constellation GP, L.P. is the general partner of Altaris Constellation Partners, L.P., and may be deemed to beneficially own the shares of common stock of the Issuer beneficially owned by Altaris Constellation Partners, L.P. Altaris Partners, LLC is the general partner of AHP Constellation GP, L.P., and may be deemed to beneficially own the shares of common stock of the Issuer beneficially owned by AHP Constellation GP, L.P.
- [F9]The securities are held of record by ACP-BHC LLC.
Documents
Issuer
Trean Insurance Group, Inc.
CIK 0001801754
Related Parties
1- filerCIK 0001777236
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 7:14 PM ET
- Size
- 36.6 KB